Work

Cyclophilins in Atherosclerosis: A New Therapeutic Target?

Year: 2013

Type: article

Source: Current Pharmaceutical Design

DOI: 10.2174/1381612811319330009

Authors: Michael Bukrinsky, Alexander Orekhov, Michael Ditiatkovski, Dmitri Sviridov

Institutions: George Washington University, Institute for Atherosclerosis Research, Baker Heart and Diabetes Institute

Language: English

Topic: Signaling Pathways in Disease

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1965780087

FWCI: 0.299

Cites:

Cited by: 3

Related to: 10